Form 4 for XRAY DENTSPLY SIRONA Inc.
Accepted 2023-03-07 00:00:00 ET · period of report 2023-03-03 · accession 0001127602-23-009272 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-07 | 2023-03-03 | XRAY | FRANK ANDREAS G | Executive VP, Product Group | A - Grant | $0.00 | +14.5K | 129.3K | +13% | $0 |
| D | 2023-03-07 | 2023-03-03 | XRAY | FRANK ANDREAS G | Executive VP, Product Group | A - Grant | $0.00 | +44.8K | 44.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-03 | A | A | 14,520 | $0.00 | 129,348.04 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-03-03 | A | A | 44,800 | $0.00 | 44,800 | D | $38.74 · — to 2023-03-03 | 44,800 Common Stock | (F2) Stock Options vest in annual one-third (1/3) increments over a three (3) year period ending March 3, 2026. |